BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11606349)

  • 1. [Reproducibility and interchangeability of the Thromboelastograph, Sonoclot and Hemochron activated coagulation time in cardiac surgery].
    Forestier F; BĂ©lisle S; Contant C; Harel F; Janvier G; Hardy JF
    Can J Anaesth; 2001 Oct; 48(9):902-10. PubMed ID: 11606349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
    Dirkmann D; Nagy E; Britten MW; Peters J
    BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass.
    Chavez JJ; Foley DE; Snider CC; Howell JC; Cohen E; Muenchen RA; Carroll RC
    Anesth Analg; 2004 Nov; 99(5):1290-1294. PubMed ID: 15502019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three point-of-care testing devices to detect hemostatic changes in adult elective cardiac surgery: a prospective observational study.
    Espinosa A; Stenseth R; Videm V; Pleym H
    BMC Anesthesiol; 2014; 14():80. PubMed ID: 25276093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.
    Welsby IJ; McDonnell E; El-Moalem H; Stafford-Smith M; Toffaletti JG
    J Clin Monit Comput; 2002 Jul; 17(5):287-92. PubMed ID: 12546261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass.
    Tuman KJ; Spiess BD; McCarthy RJ; Ivankovich AD
    Anesth Analg; 1989 Jul; 69(1):69-75. PubMed ID: 2742171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of bleeding diathesis in patients undergoing cardiopulmonary bypass during cardiac surgery: viscoelastic measures versus routine coagulation test.
    Shih RL; Cherng YG; Chao A; Chen JT; Tsai AL; Liu CC
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):133-9. PubMed ID: 9407676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying platelet gel coagulation using Sonoclot and Thrombelastograph hemostasis analyzer.
    Cassidy LK; Finney AS; Ellis WC; Spiwak AJ; Riley JB
    J Extra Corpor Technol; 2005 Mar; 37(1):48-51. PubMed ID: 15804157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery.
    Galeone A; Rotunno C; Guida P; Bisceglie A; Rubino G; Schinosa Lde L; Paparella D
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):853-8. PubMed ID: 23627997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice.
    Matte GS; Howe RJ; Ibla J; Emani S; Emani SM
    J Extra Corpor Technol; 2019 Dec; 51(4):221-226. PubMed ID: 31915405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
    Paniccia R; Fedi S; Carbonetto F; Noferi D; Conti P; Bandinelli B; Giusti B; Evangelisti L; Pretelli P; Palmarini MF; Abbate R; Prisco D
    Anesthesiology; 2003 Jul; 99(1):54-9. PubMed ID: 12826842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaolin-activated thromboelastography and standard coagulation assays in cyanotic and acyanotic infants undergoing complex cardiac surgery: a prospective cohort study.
    Rizza A; Ricci Z; Pezzella C; Favia I; Di Felice G; Ranucci M; Cogo P
    Paediatr Anaesth; 2017 Feb; 27(2):170-180. PubMed ID: 27935164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interchangeability of activated clotting time values across different point-of-care systems.
    Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
    Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference values for kaolin-activated thromboelastography in healthy children.
    Chan KL; Summerhayes RG; Ignjatovic V; Horton SB; Monagle PT
    Anesth Analg; 2007 Dec; 105(6):1610-3, table of contents. PubMed ID: 18042858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT.
    Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK
    Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.